AdvantAge

WHAT IS A JOINT ACTION?

Joint Actions are a funding instrument under the third EU Health Programme 2014-2020. They are designed and financed by Member State authorities and the EU to address specific priorities under the EU Health Programme. Joint Actions have a clear EU added value – they are expected to contribute to solving problems at the European level, and to have a greater impact that single national activities, especially at policy making level. They are co-financed either by competent authorities that are responsible for health in the Member States (e.g. Health Ministries) or in the third countries participating in the Programme, or by public sector bodies and non-governmental bodies mandated by those competent authorities. Joint Actions involve on average 25 partners, depending on the scope of the action, must be related to the existing EU policies in the field of public health and in other policy fields and must not duplicate actions that can be taken at Member State level.

Press here for further information JOINT ACTION FACT SHEET.


ADVANTAGE JA -“A comprehensive approach to promote a disability-free Advanced age in Europe: the ADVANTAGE initiative”

ADVANTAGE is a Joint Action with 22 Member States (MS) and 33 organizations involved. It is co-funded by the European Union and the MS.
Partners work together to summarize the current State of the Art of the different components of frailty and its management, both at a personal and population level and increase knowledge in the field of frailty to build a common understanding on frailty to be used by participating MS.
The final output will be the “Frailty prevention approach” (FPA), a common European model to tackle frailty and indicate what should be prioritized in the next years at European, National and Regional level and on which to base a common management approach of older people who are frail or at risk of developing frailty in the European Union (EU).
The identification of the core components of frailty and its management should promote the needed changes in the organization and the implementation of the Health and Social Systems. This will support sustainable models of care that, taking into consideration the particular health profile of each MS, will allow them to face the challenge of frailty within a common framework.
ADVANTAGE JA addresses policy makers involved in planning and developing health and social care policies and strategies for older people; health and social care professionals and formal and informal carers, who implement the necessary changes into the everyday practice; and frail older people, or those at risk of frailty, as well as the EU population at large.
This will lead to the development and implementation of improved strategies for diagnosis, care, research, and education about frailty, disability and multi-morbidity. This will also reduce the burden and inefficiency in care delivery through support for self-management, better care planning and coordination, innovative organisational approaches and better collaboration between professional and informal care.


WHAT IS THE EUROPEAN COMMISSION’S ROLE?

It implements the EU Consumer Programme and the Better Training for Safer Food initiative as well as the EU Health Programme, which co-funds the ADVANTAGE Joint Action.
The Consumers, Health and Food Executive Agency (CHAFEA) provides a professional service in performing the tasks and activities entrusted to it by the European Commission (EC), and it works closely with the EC Directorate-General Health and Food Safety (DG SANTE) that has the policy leadership on the EU health related policies aiming to protect and improve public health.

Press here for further information on EC, DG SANTE and CHAFEA.

 

logo MUG rev01The Medical University of Graz comprises of 16 Research Institutes, 20 Clinical Departments and a purpose built Center for Medical Research equipped with highly specialized core facilities as well as lab and office space for research projects. The number of employees is about 1700. Approx. 4500 students are enrolled in the study programmes (Human Medicine, Dentistry, Nursing Science, Doctoral Programs) and postgraduate programs. The University runs internationally accredited PhD Programs which offer toplevel training and research in topics Research activities at the Medical University of Graz cover a broad spectrum in clinical and preclinical fields. The University has been participating in numerous EUfunded projects (FP5, 6, 7 and Horizon2020, Joint Action, JPI/HDL) and acts as coordinator of various large research initiatives.

www.medunigraz.at

 

The Hospital Universitario de Getafe (SERMAS-HUG) is the structure that integrates all the 31 public hospitals and every public health service of the Madrid Regional Health System, including the University Hospital of Getafe, with a large tradition in caring for older patients. Its Geriatric Department works since 1991 and currently attends patients along its Units: Acute Care Unit (1800 patients/year), Orthogeriatric and Interconsultation Unit (800 patients/year), Day Hospital (300 patients/year), Outpatient Office (4000 patients/year), and Domiciliary Care Unit (1200 patients/year).

www.madrid.org/hospitalgetafe

 

 

Affiliated entities:

FUNDACION INVESTIGACION GETAFE
The Biomedical Research Foundation (Fundación para la Investigación Biomédica del Hospital Universitario de Getafe, FIB-HUG) was founded in 2003 as a non-profit entity to support and enhance the research and training activities in the area of health sciences. It is the administrative tool  of the  hospital to manage the administrative tasks and financial issues regarding research activities, including employment of professionals and purchase of equipment. Currently, there are 3 parallel strands of research activity: a) frailty, aging  and incapacity b) chronic and inflammatory diseases and c) cancer.

The FIB-HUG is situated in the premises of the hospital. It is one of the affiliated entities of SERMAS-HUG for the ADVANTAGE JA.

 

logoSESCAM

SESCAM is one of the affiliated entities of SERMAS-HUG for the ADVANTAGE JA implementation.  The SESCAM is the Regional Health Service of Castilla la Mancha (CLM). It was created in 2002 to give a health public coverage: universal, equitable, integrated, that should provide a high quality health services to CLM population. The region has just over two million people with an aging rate of 19.4% and a life expectancy at birth of 80.4 years. To provide health, The regional health system is organized in 8 health areas that manage 16 hospitals (5,154 beds), 199 health care centers and eight of intermedate care centers (TDCs) which employ 25,000 people. The Regional Health budget reaches 2.7 Billions of Euros (28% of Regional Total Budget). Since its inception the SESCAM opted for ICTs, result of this, is a system that integrates with high efficiency, information and health assistance, that results in a decrease of care GAPs. The SESCAM has experience in managing research projects of international calls, between other projects: PUMA. Measurement and Actuation Pressure Ulcer, BIOMOT. Smart Wearable Robots With Bioinspired Sensory-Motor Skills, NEURIMP NEURIMP. Novel combination of biopolymers and manufacturing technologies for production of a peripheral nerve implant, AIDPATH. Academia and Industry Collaboration for Digital Pathology of European 7P. and FRAILOMIC (FP7 Program) a research iniciative dedicated to identifying biomarkers of frailty.

To the SESCAM belong the departments of geriatrics of Toledo and Albacete Hospitals that lead two epidemiological studies dedicated to the study of frailty (Toledo Study for Healthy Aging and Fradea Study).

 

SIGN UP FOR OUR NEWSLETTER AND FOLLOW US

Click on This email address is being protected from spambots. You need JavaScript enabled to view it. and send.

 

Newsletter n.1

Newsletter n.2

Newsletter n.3